CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer
No Thumbnail Available
Issue Date
2026
Our author(s)
Srinivasan, G.
Department
Oncology
Keywords
Oncology , Pharmacology
Language
en
Publisher
American Society of Clinical Oncology
ISSN
0732-183X
eISSN
1527-7755
ISBN
Type
article
Citation
Jackson-Spence, F., Larkin, J., Patel, P., Valderrama, B.P., Rodriguez-Vida, A., Glen, H., Thistlethwaite, F.C., Ralph, C., Srinivasan, G., Mendez-Vidal, M.J., Childress, M., Li, W., Boyle, P., Gasco, A., Markovets, A., Hartmaier, R., Ackerman, C., Szabados, B.E., Priyadarshini, G., Jamal, F., Powles, T. & Suarez, C. 2026 CALYPSO: Final Results of Savolitinib and Durvalumab Combination in Metastatic Papillary Renal Cancer. Journal of Clinical Oncology, Mar 20, (Online ahead of print).